Understanding the Drivers of CAB PrEP Uptake and Use among Women in sub-Saharan Africa to Build Demand for New PrEP Methods.

Autor: Bishopp C; Family Health International 360, Durham, NC, USA. cbishopp@fhi360.org., Mungai-Barris Z; Mann Global Health, Columbus, NC, USA., Briedenhann E; University of the Witwatersrand, Johannesburg, South Africa., Donaldson E; Family Health International 360, Durham, NC, USA., Irungu E; Jhpiego, Nairobi, Kenya., Schwartz K; Family Health International 360, Durham, NC, USA.
Jazyk: angličtina
Zdroj: Current HIV/AIDS reports [Curr HIV/AIDS Rep] 2024 Dec 07; Vol. 22 (1), pp. 7. Date of Electronic Publication: 2024 Dec 07.
DOI: 10.1007/s11904-024-00715-y
Abstrakt: Purpose of Review: As injectable cabotegravir for pre-exposure prophylaxis (CAB PrEP) is introduced in sub-Saharan Africa, it is important to understand how behavioral drivers may influence women's decisions around whether or not to use it.
Recent Findings: Facilitating factors include prior familiarity with injections and the perceived efficacy of CAB PrEP, while barriers include a fear or dislike of needles and negative attitudes held by community members and influencers. Further research is needed to fully understand behavioral factors affecting African women's CAB PrEP use. HIV prevention policymakers, practitioners, advocates, and clients are optimistic about CAB PrEP, predicting that this long-acting method will be popular among women in sub-Saharan Africa. However, women may also face barriers to use. Knowledge of behavioral facilitators and barriers can enhance the adaptation or development of HIV prevention communication and demand generation strategies that support informed decision-making in a multi-method market.
Competing Interests: Declarations. Competing Interests: The authors declare no competing interests.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: